Qianjiang Biochemical announced that revenue for the first half of 2026 was 733 million yuan, down 5.95% year on year; net profit attributable to shareholders of listed companies was 777.648 million yuan, down 27.40% year on year, and 107 million yuan for the same period in 2025; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 776.081 million yuan, up 36.77% year on year.

Qianjiang Biochemical announced that revenue for the first half of 2026 was 733 million yuan, down 5.95% year on year; net profit attributable to shareholders of listed companies was 777.648 million yuan, down 27.40% year on year, and 107 million yuan for the same period in 2025; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 776.081 million yuan, up 36.77% year on year.